Salvifarinin A, a neo-clerodane diterpenoid with a 6/5/7 tricyclic skeleton from Salvia farinacea
文献类型:期刊论文
| 作者 | Fan, Min1,2 ; Chen, Xue-Jiao1,2; Wu, Xing-De1; Shao, Li-Dong1; Ji, Xu1 ; Zhao, Qin-Shi1
|
| 刊名 | TETRAHEDRON LETTERS
![]() |
| 出版日期 | 2018-08-08 |
| 卷号 | 59期号:32页码:3065-3068 |
| 关键词 | Neo-clerodane Diterpenoids Salvia Farinacea Lipid-lowering Activity |
| ISSN号 | 0040-4039 |
| DOI | 10.1016/j.tetlet.2018.06.015 |
| 英文摘要 | Salvifarinin A (1), a rearrangement product of Languidulane-type clerodane diterpenoids with a 6/5/7 tricyclic ring skeleton fused with gamma-lactone ring and furan ring, and two new biogenetically related diterpernoids, salvifarinins B (2) and C (3), were isolated from the aerial parts of Salvia farinacea. The absolute configuration of 1 was elucidated by extensive spectroscopic methods, and confirmed by single crystal X-ray diffraction and bio-inspired semisynthesis. The plausible biogenetic pathway was also proposed. Compound 2 displayed a potent effect on reducing hepatic steatosis. (C) 2018 Published by Elsevier Ltd. |
| 语种 | 英语 |
| 源URL | [http://ir.kib.ac.cn/handle/151853/61700] ![]() |
| 专题 | 昆明植物研究所_植物化学与西部植物资源持续利用国家重点实验室 |
| 作者单位 | 1.Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resources West Ch, Kunming 650201, Yunnan, Peoples R China 2.Univ Chinese Acad Sci, Beijing 100049, Peoples R China |
| 推荐引用方式 GB/T 7714 | Fan, Min,Chen, Xue-Jiao,Wu, Xing-De,et al. Salvifarinin A, a neo-clerodane diterpenoid with a 6/5/7 tricyclic skeleton from Salvia farinacea[J]. TETRAHEDRON LETTERS,2018,59(32):3065-3068. |
| APA | Fan, Min,Chen, Xue-Jiao,Wu, Xing-De,Shao, Li-Dong,Ji, Xu,&Zhao, Qin-Shi.(2018).Salvifarinin A, a neo-clerodane diterpenoid with a 6/5/7 tricyclic skeleton from Salvia farinacea.TETRAHEDRON LETTERS,59(32),3065-3068. |
| MLA | Fan, Min,et al."Salvifarinin A, a neo-clerodane diterpenoid with a 6/5/7 tricyclic skeleton from Salvia farinacea".TETRAHEDRON LETTERS 59.32(2018):3065-3068. |
入库方式: OAI收割
来源:昆明植物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


